Zhejiang Taimei Medical Technology Co Ltd Class H (2576) Stock Statistics & Valuation Metrics

Zhejiang Taimei Medical Technology Co Ltd Class H has a market cap or net worth of HK$2.72B. The enterprise value is HK$755.50M.

Zhejiang Taimei Medical Technology Co Ltd Class H has 200,592,530 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zhejiang Taimei Medical Technology Co Ltd Class H’s return on equity (ROE) is -0.19 and return on invested capital (ROIC) is -19.24%.

The current PE Ratio of Zhejiang Taimei Medical Technology Co Ltd Class H is ―. Zhejiang Taimei Medical Technology Co Ltd Class H’s PEG ratio is 0.28.

In the last 12 months, Zhejiang Taimei Medical Technology Co Ltd Class H had revenue of 551.16M and earned -214.61M in profits. Earnings per share was -0.39.

In the last 12 months, operating cash flow was -112.56M and capital expenditures -512.42K, giving a free cash flow of -113.03M billion.

Zhejiang Taimei Medical Technology Co Ltd Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Zhejiang Taimei Medical Technology Co Ltd Class H upcoming earnings date is Aug 28, 2025, Before Open (Not Confirmed).

Zhejiang Taimei Medical Technology Co Ltd Class H as a current ratio of 5.05, with Debt / Equity ratio of 3.00%

In the past 12 months, Zhejiang Taimei Medical Technology Co Ltd Class H has paid 0.00 in taxes.

Zhejiang Taimei Medical Technology Co Ltd Class H EV to EBITDA ratio is -11.21, with an EV/FCF ratio of -9.56.

Zhejiang Taimei Medical Technology Co Ltd Class H has HK$978.70M in cash and marketable securities with HK$13.71M in debt, giving a net cash position of HK$965.00M billion.

Gross margin is 38.20%, with operating margin of -45.80%, and net profit margin of -38.94%.

The average price target for Zhejiang Taimei Medical Technology Co Ltd Class H is HK$4.50, which is 11.43% higher than the current price. The consensus rating is Hold